Johnson & Johnson has secured U.S. regulatory clearance for its newest electrophysiology device, the Dual Energy THERMOCOOL SMARTTOUCH SF Platform. The system lets doctors switch between radiofrequency and pulsed field energy within a single catheter, giving them flexibility to tailor heart ablation procedures to each patient’s anatomy.
The device builds on J&J’s existing SMARTTOUCH SF catheter line, which the company says has already been used in more than a million U.S. procedures, now enhanced with pulsed field capability and full compatibility with its CARTO mapping and imaging system. Company leadership described the clearance as part of a particularly active stretch of innovation for the business, following the technology’s earlier launch in European markets.
An outside cardiologist consulted by the company noted that having both energy options within one connected system could help physicians manage more complicated cases with greater confidence. J&J expects U.S. hospitals to begin performing procedures with the new platform this summer, as it rolls out commercially in stages.
Written By: Sayan Das
Graphics by: Pramit Hazra
